miltefosine has been researched along with Irritable Bowel Syndrome in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botschuijver, S | 1 |
| van Diest, SA | 1 |
| van Thiel, IAM | 1 |
| Saia, RS | 1 |
| Strik, AS | 1 |
| Yu, Z | 1 |
| Maria-Ferreira, D | 1 |
| Welting, O | 1 |
| Keszthelyi, D | 1 |
| Jennings, G | 1 |
| Heinsbroek, SEM | 1 |
| Elferink, RPO | 1 |
| Schuren, FHJ | 1 |
| de Jonge, WJ | 1 |
| van den Wijngaard, RM | 1 |
| Pisipati, S | 1 |
| Connor, BA | 1 |
| Riddle, MS | 1 |
1 review available for miltefosine and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome.
Topics: Adult; Animals; Anti-Bacterial Agents; Child; Colon; Gastroenteritis; Humans; Infections; Inflammati | 2020 |
1 other study available for miltefosine and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Topics: Abdominal Pain; Animals; Antifungal Agents; Female; Fungi; Gastrointestinal Microbiome; Humans; Irri | 2019 |